Your browser doesn't support javascript.
loading
Infants Harness the Germline against RSV.
Fox, Annette; Subbarao, Kanta; Reading, Patrick.
Afiliação
  • Fox A; WHO Collaborating Centre for Reference and Research on Influenza, Melbourne, VIC, Australia; Department of Microbiology and Immunology, The University of Melbourne, Peter Doherty Institute for Infection and Immunity, Parkville, VIC, Australia. Electronic address: annette.fox@unimelb.au.
  • Subbarao K; WHO Collaborating Centre for Reference and Research on Influenza, Melbourne, VIC, Australia; Department of Microbiology and Immunology, The University of Melbourne, Peter Doherty Institute for Infection and Immunity, Parkville, VIC, Australia. Electronic address: kanta.subbarao@influenzacentre.org.
  • Reading P; WHO Collaborating Centre for Reference and Research on Influenza, Melbourne, VIC, Australia; Department of Microbiology and Immunology, The University of Melbourne, Peter Doherty Institute for Infection and Immunity, Parkville, VIC, Australia.
Immunity ; 48(2): 190-192, 2018 02 20.
Article em En | MEDLINE | ID: mdl-29466748
In this issue of Immunity, Goodwin et al. (2018) offer hope for an RSV vaccine for young infants by demonstrating that RSV infection in very young infants induces neutralizing antibodies that are close to the germline and have unusual epitope specificity.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Limite: Humans / Infant Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Limite: Humans / Infant Idioma: En Ano de publicação: 2018 Tipo de documento: Article